Anti-AChR, anti-RYR1, and anti-TTN antibodies were tested in 13 available sera from non-MG thymoma patients, including 7 patients with type A/AB, 5 patients with type B1/B2, and 1 patient with type B3/B3 mixed thymoma. Here, RYR1 is linked to thymoma.